Related Experiment Video
Updated: Sep 11, 2025
Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design
Published on: May 31, 2021
Perceived quality of life using IMPACT-III in a sample of Colombian children with IBD in remission: a cross-sectional
Viviana Parra-Izquierdo1, Juan Sebastián Frías-Ordoñez2, Fabián E Puentes M3
1International Hospital of Colombia, Bucaramanga, Colombia; Cellular and Molecular Immunology Group (INMUBO), Universidad El Bosque, Bogotá, Colombia; Colombian Foundation of Inflammatory Bowel Disease (FUNEIICO), Colombia.
Insights
Quality of life for children with inflammatory bowel disease (IBD) in Colombia is challenging, impacting emotional and systemic well-being. Further support and education are crucial for pediatric IBD patients.
Area of Science:
- Pediatric Gastroenterology
- Quality of Life Research
- Chronic Disease Management
Background:
- Limited data exists on the quality of life (QoL) for pediatric patients with inflammatory bowel disease (IBD) in Colombia.
- Assessing QoL is crucial for understanding the holistic impact of IBD on young patients.
Purpose of the Study:
- To determine the quality of life (QoL) in a Colombian sample of pediatric IBD patients.
- Utilized the validated IMPACT-III questionnaire for QoL assessment.
Main Methods:
- A cross-sectional study was conducted between June and November 2022, involving pediatric IBD patients from three different Colombian cities.
- The IMPACT-III questionnaire, assessing QoL on a scale of 35-175 (higher scores indicate better QoL), was administered once to eligible participants.
- Data was collected from 33 pediatric patients diagnosed with either ulcerative colitis (UC) or Crohn's disease (CD).
Main Results:
- The study included 33 pediatric patients (69.7% female, mean age 14.9 years), with 94% experiencing inactive or mild disease.
- Median IMPACT-III scores were 147 for ulcerative colitis (UC) and 126 for Crohn's disease (CD).
- Systemic symptoms and emotional functioning were the most affected domains, with lower scores observed in both UC and CD patient groups.
Conclusions:
- Pediatric IBD patients in Colombia face significant challenges impacting their quality of life.
- Emotional and systemic aspects of well-being require particular attention.
- Enhanced patient support and educational initiatives are recommended to improve QoL for children with IBD.
Introduction:
No data on quality of life (QoL) in paediatric IBD in Colombia. The aim of this study was to determine QoL using the IMPACT-III questionnaire in a sample of patients from different centres.
Materials And Methods:
Cross-sectional study of paediatric IBD patients followed in 3 centres in different cities, between June and November 2022. Eligible subjects were identified, information was collected on different dates, and the IMPACT-III questionnaire (score ranges from 35 to 175, with higher scores indicating better QoL) was administered once.
Results:
33 patients were included. 23/33 (69.7%) female, mean age 14.9 (range 6-17.9) years. 94% with inactive or mild disease. 20 patients with ulcerative colitis (UC), 13 with Crohn's disease (CD). The median score in UC was 147 (122-152), while in CD it was 126 (105-135). Systemic symptoms and emotional functioning were most affected, with median scores of 13 (12-14) and 27 (20-31) in UC and 11 (9-11) and 23 (20-26) in CD. No statistically significant differences were observed.
Conclusions:
The quality of life of children with IBD is challenging due to several factors. More support and education is needed for these patients.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:29Assessment of the Gastrointestinal System II: Health Perception Pattern
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
01:30Irritable Bowel Syndrome III: Medical and Nursing Management